MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
Fulgent Genetics Operating Cycle 2011-2026 | FLGT
Annual Operating Cycle Fulgent Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.4 | 65.5 | 56.5 | 59.4 | 82.4 | 87.9 | 117 | 93.2 | 109 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 | 56.5 | 83.2 |
Quarterly Operating Cycle Fulgent Genetics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80.5 | 82.9 | 87.3 | - | 72.4 | 69.8 | 73 | - | 45.3 | 52.7 | 66.4 | - | 45 | 58.3 | 42.6 | 47.1 | 53.9 | 108 | 50.8 | 56.9 | 165 | 972 | 1.12 K | 71.3 | 57.8 | 71 | 106 | 95.7 | 96.5 | 101 | 97.6 | 85.4 | 81.2 | 78.8 | 72 | 68 | 79.5 | 100 | 86 | 66.6 | 33.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.12 K | 33.3 | 126 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
|
Biodesix
BDSX
|
41.7 | $ 13.64 | -6.58 % | $ 1.77 B |  USA |
 |
DarioHealth Corp.
DRIO
|
227 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 477.84 | -2.25 % | $ 180 B | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
128 | $ 565.93 | -1.28 % | $ 45.5 B | USA |
 |
Illumina
ILMN
|
198 | $ 118.67 | -4.61 % | $ 18.9 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.61 | -0.62 % | $ 61.9 M |  Irlanda |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 238.69 | -2.47 % | $ 25.5 B |  Schweiz |
 |
Co-Diagnostics
CODX
|
405 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
29.4 | $ 17.21 | -0.86 % | $ 385 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 158.35 | -4.21 % | $ 7.85 B | USA |
 |
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
834 | $ 291.81 | -2.91 % | $ 17.4 B | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
412 | $ 4.75 | 3.38 % | $ 2.55 M | USA |
 |
Personalis
PSNL
|
55.8 | $ 6.55 | -10.52 % | $ 388 M | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | USA |
 |
Exagen
XGN
|
51.2 | $ 2.68 | -4.12 % | $ 57.8 M | USA |
 |
Interpace Biosciences
IDXG
|
79.2 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
34.5 | $ 56.85 | -4.31 % | $ 4.27 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B |  Niderland |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 6.54 | -0.3 % | $ 273 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 266.88 | -0.56 % | $ 22.2 B | USA |
 |
VolitionRx Limited
VNRX
|
52.3 | $ 0.2 | 0.03 % | $ 19.2 M |  Singapore |
 |
Psychemedics Corporation
PMD
|
61.3 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
49.8 | $ 26.75 | -1.65 % | $ 34.7 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 17.11 | -2.06 % | $ 912 M | USA |
 |
Neuronetics
STIM
|
69.1 | $ 1.4 | 5.26 % | $ 92.3 M | USA |
 |
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M | Schweiz |